C. Barbagelata

Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

F. Pomero, L. Mazzolai, P. Prandoni, 2021, Journal of the American Heart Association.

First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

L. Mazzolai, P. Prandoni, E. Grandone, 2020 .

Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

Juan Manuel García, José Antonio Trujillo, C. Molina, 2018, Revista Clínica Española (English Edition).

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

P. Prandoni, L. Bertoletti, P. Verhamme, 2021, Internal and Emergency Medicine.

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

L. Jara-Palomares, A. Maestre, G. Vidal, 2023, Research and Practice in Thrombosis and Haemostasis.

Factors associated with poor anticoagulation control with vitaminK antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study.

Fernando Diaz, Ignacio Aguaded, J. A. Díaz, 2018, Revista clinica espanola.